Search results
Barclays cuts Gilead Sciences stock target, reiterates Equalweight rating By Investing.com
Investing.com· 5 days agoOn Monday, Barclays made adjustments to its outlook on Gilead Sciences (NASDAQ:GILD), a...
Valmark Advisers Inc. Cuts Stock Position in Gilead Sciences, Inc. (NASDAQ:GILD)
ETF DAILY NEWS· 5 days agoValmark Advisers Inc. decreased its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 14.6% during the fourth quarter, according ...
Analyst Report: Gilead Sciences, Inc.
Morningstar Research via Yahoo Finance· 20 hours agoGilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis ...
Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by Savant Capital LLC
ETF DAILY NEWS· 2 days agoSavant Capital LLC cut its holdings in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 3.3% during the 4th quarter, according to its most recent Form ...
Gilead Sciences (NASDAQ:GILD) Earns Hold Rating from Needham & Company LLC
ETF DAILY NEWS· 6 days agoNeedham & Company LLC reiterated their hold rating on shares of Gilead Sciences (NASDAQ:GILD – Free Report) in a research report sent to investors on Friday ...
The Zacks Analyst Blog Highlights Gilead Sciences, GSK, Deciphera, Bristol Myers and Editas Medicine
Zacks via Yahoo Finance· 1 day agoEvery day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and...
Gilead Sciences, Inc. (GILD) Is a Trending Stock: Facts to Know Before Betting on It
Zacks via Yahoo Finance· 5 days agoGilead (GILD) has received quite a bit of attention from Zacks.com users lately. Therefore, it is...
Gilead Sciences (NASDAQ:GILD) Stock Rating Upgraded by StockNews.com
ETF DAILY NEWS· 6 days agoHSBC upgraded shares of Gilead Sciences from a “reduce” rating to a “hold” rating and set a $69.00 price objective on the stock in a research note on Wednesday ...
Gilead Sciences, Inc. [NASDAQ: GILD] Sees Decrease in Stock Value – Knox Daily
Knox Daily· 2 days agoInvestors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Gilead Sciences, Inc. shares valued at $368,790 were ...
Gilead Sciences, Inc. (GILD): Be Patient, You Will Learn – Stocks Register
Stocks Register· 2 days agoGilead Sciences, Inc. (NASDAQ:GILD) at last check was buoying at $64.49 on Friday, May 03, with a fall of -1.29% from its closing price on previous day.
